Frankfurt - Delayed Quote EUR

Bio-Gate AG (BIG1.F)

Compare
0.7150 +0.0150 (+2.14%)
As of 5:20:01 PM GMT+1. Market Open.
Loading Chart for BIG1.F
DELL
  • Previous Close 0.7000
  • Open 0.7050
  • Bid 0.7050 x --
  • Ask 0.7500 x --
  • Day's Range 0.7050 - 0.7250
  • 52 Week Range 0.5350 - 1.3800
  • Volume 200
  • Avg. Volume 213
  • Market Cap (intraday) 6.751M
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company's products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was incorporated in 2005 and is based in Nuremberg, Germany.

www.bio-gate.de

45

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIG1.F

View More

Performance Overview: BIG1.F

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIG1.F
3.38%
DAX P
1.54%

1-Year Return

BIG1.F
30.58%
DAX P
21.13%

3-Year Return

BIG1.F
83.68%
DAX P
26.76%

5-Year Return

BIG1.F
52.65%
DAX P
49.79%

Compare To: BIG1.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIG1.F

View More

Valuation Measures

As of 1/9/2025
  • Market Cap

    5.92M

  • Enterprise Value

    5.44M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.86

  • Price/Book (mrq)

    2.82

  • Enterprise Value/Revenue

    0.72

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -26.32%

  • Return on Assets (ttm)

    -25.82%

  • Return on Equity (ttm)

    -68.91%

  • Revenue (ttm)

    7.61M

  • Net Income Avi to Common (ttm)

    -2M

  • Diluted EPS (ttm)

    -0.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    476k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -169.26k

Research Analysis: BIG1.F

View More